Literature DB >> 22127477

Sudomotor dysfunction in autoimmune autonomic ganglionopathy: a follow-up study.

Kurt Kimpinski1, Valeria Iodice, Paola Sandroni, Robert D Fealey, Steven Vernino, Phillip A Low.   

Abstract

OBJECTIVE: We have previously shown that sudomotor dysfunction in autoimmune autonomic ganglionopathy is severe, widespread, and predominantly post-ganglionic. However, the long-term changes in sudomotor function have not been studied in detail. Our objective was to characterize the long-term changes in sudomotor dysfunction in patients with autoimmune autonomic ganglionopathy.
METHODS: Changes in sudomotor function were compared in a cohort of nine α3 nAChR antibody positive autoimmune autonomic ganglionopathy patients over an approximate 5-year period. Standard measurements of sudomotor function were used including the thermoregulatory sweat test and quantitative sudomotor axon reflex test.
RESULTS: Total body anhidrosis on thermoregulatory sweat testing showed improvement in four of nine patients. Quantitative sudomotor axon reflex testing for both forearm and foot sites was variable with four of nine patients showing improvement in total sweat output. Distribution of sudomotor dysfunction at follow-up was post-ganglionic in seven of nine patients at the foot site and three of nine patients at the forearm site. Overall, sudomotor dysfunction was post-ganglionic in seven of nine patients throughout the follow-up period (62.4 ± 19.4 months).
INTERPRETATION: Sudomotor dysfunction in autoimmune autonomic ganglionopathy was severe and widespread throughout the follow-up period for the majority of patients studied. Sudomotor dysfunction was predominantly post-ganglionic throughout the follow-up period.

Entities:  

Mesh:

Year:  2011        PMID: 22127477      PMCID: PMC3469317          DOI: 10.1007/s10286-011-0152-4

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  16 in total

Review 1.  Evaluation of sudomotor function.

Authors:  Phillip A Low
Journal:  Clin Neurophysiol       Date:  2004-07       Impact factor: 3.708

2.  Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies.

Authors:  S Vernino; P A Low; R D Fealey; J D Stewart; G Farrugia; V A Lennon
Journal:  N Engl J Med       Date:  2000-09-21       Impact factor: 91.245

3.  Neuronal ganglionic acetylcholine receptor autoimmunity.

Authors:  Steven Vernino; Vanda A Lennon
Journal:  Ann N Y Acad Sci       Date:  2003-09       Impact factor: 5.691

4.  Sudomotor dysfunction in autoimmune autonomic ganglionopathy.

Authors:  K Kimpinski; V Iodice; P Sandroni; R D Fealey; S Vernino; P A Low
Journal:  Neurology       Date:  2009-11-03       Impact factor: 9.910

5.  Composite autonomic scoring scale for laboratory quantification of generalized autonomic failure.

Authors:  P A Low
Journal:  Mayo Clin Proc       Date:  1993-08       Impact factor: 7.616

6.  Idiopathic autonomic neuropathy: comparison of cases seropositive and seronegative for ganglionic acetylcholine receptor antibody.

Authors:  Paola Sandroni; Steven Vernino; Caroline M Klein; Vanda A Lennon; Lisa Benrud-Larson; David Sletten; Phillip A Low
Journal:  Arch Neurol       Date:  2004-01

7.  Experimental autoimmune autonomic neuropathy.

Authors:  Steven Vernino; Phillip A Low; Vanda A Lennon
Journal:  J Neurophysiol       Date:  2003-05-28       Impact factor: 2.714

8.  Mechanisms of acetylcholine receptor loss in myasthenia gravis.

Authors:  D B Drachman; R N Adams; E F Stanley; A Pestronk
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-07       Impact factor: 10.154

9.  Passive transfer of autoimmune autonomic neuropathy to mice.

Authors:  Steven Vernino; Leonid G Ermilov; Lei Sha; Joseph H Szurszewski; Phillip A Low; Vanda A Lennon
Journal:  J Neurosci       Date:  2004-08-11       Impact factor: 6.167

10.  Thermoregulatory sweating abnormalities in diabetes mellitus.

Authors:  R D Fealey; P A Low; J E Thomas
Journal:  Mayo Clin Proc       Date:  1989-06       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.